Market Research Reports

Array Instruments Market (Technologies DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays End Users Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Forensic Centers, Veterinary Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

85pages
Published Date: 2014-08-05
 

Description


This report on the array instruments market studies the current as well as future prospects of the market globally. Microarray technology though a traditional bio technological tool, is gaining a rapidly evolving and emerging technology. Microarrays concept and methodology was first introduced in 1983 by Tse Wen Chang in a scientific publication. The microarray industry grew significantly after the 1995 Science Paper by the Ron Davis and Pat Brown labs at Stanford University. The technology of DNA microarrays has become the most sophisticated and the most widely used, with the establishment of companies such as Affymetrix, Inc., Agilent Technologies, Illumina, Inc., ArrayIt  Corporation and others, while the use of protein, peptide, cells, tissue and carbohydrate microarrays are expanding. The technology is used to detect, assess and analyze the interaction between different molecules such as DNA, RNA, proteins, siRNA, pharmaceuticals, carbohydrates, and antibodies. This report includes an elaborate executive summary, which covers a market snapshot that provides overall information of various segments that are contained in the report. It also provides an overall information and data analysis of the global array instruments market with respect to market segments based on technology, end users as well as geographic regions. 

The array instruments market is segmented based on major technologies into four categories: DNA microarrays, protein microarrays, cellular microarrays and tissue microarrays. The market for these microarray technologies has been extensively analyzed based on usefulness, effectiveness, sales revenue of the instruments based on the technologies and geographic presence. The market size and forecast in terms of USD million for each technology type and end user segment has been provided for the period 2012 to 2020. The report on the array instruments market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2012 and 2013 as the base year.

The array instruments market is also segmented based on major end user areas of the major microarray technologies into four major categories: research and development laboratories, clinical diagnostic labs, agriculture research centers and veterinary laboratories. The market for these end users of microarray technologies has been extensively analyzed based on the percentage adoption of these technologies in these sectors. The market size and forecast in terms of USD million for each end user has been provided for the period 2012 to 2020. The report on the array instrument market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2012 and 2013 as the base year.

Geographically, the array instruments market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The report also includes the market size and forecast for each microarray technology in respective regions. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global array instruments market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key players’ market share analysis in 2013 in the array instruments market. 

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the array instrument market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Affymetrix, Inc., Illumina, Inc., Agilent Technologies, Inc., Molecular Devices, LLC, Bio-Rad Laboratories, Thermo Fischer Scientific, ArrayIt Corporation, and Sigma Aldrich Corporation.

The global array instruments market is segmented as follows:

Array Instruments Market, by Technology
  • DNA Microarrays
  • Protein Microarrays
  • Cellular Microarrays
  • Tissue Microarrays
Array Instruments Market, by End-Users
  • Research and Development Laboratories
  • Clinical Diagnostic Labs
  • Agriculture Research Centers
  • Veterinary Laboratories
  • Forensic Centers
Array Instruments Market, by Geography
  • North America
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Europe
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Asia-Pacific
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays
  • Rest of the World (RoW)
    • DNA Microarrays
    • Protein Microarrays
    • Cellular Microarrays
    • Tissue Microarrays

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research 
      1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Array Instruments Market
2.2 Global Array Instruments, Market Revenue, 2013 (USD Million)
2.3 Comparative Analysis: Global Array Instruments Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Array Instruments, Market Overview
3.1 Introduction
3.2 Applications for Microarray Technology
      3.2.1 Gene Expression Profiling
      3.2.2 Determination of Response to Drug Treatment
      3.2.3 Toxicology
      3.2.4 Comparative Genomic Hybridization
      3.2.5 Identification of Single Nucleotide Polymorphs (SNPs)
3.3 New Microarray Technologies
3.4 Event Impact analysis
3.5 Regulatory Scenario and Bioinformatics
3.6 Market Dynamics
      3.6.1 Market Drivers
              3.6.1.1 High throughput and advances in labeling and detection to boost the demand for microarray technology in routine use
              3.6.1.2 Need for early cancer detection and diagnosis to increase the use of microarray technology
              3.6.1.3 Robotics playing a major role in laboratory automation to drive the market
              3.6.1.4 Increasing applications in life sciences and drug discovery to demand use of microarrays
      3.6.2 Market Restrains
               3.6.2.1 Lack of efficient data analysis tools to hamper the market growth
               3.6.2.2 Low adoption and penetration in developing countries due to cost of technology affecting the use of microarray technology
               3.6.2.3 Increasing competition from newer technologies to have a high impact on the microarray instruments growth
      3.6.3 Market Opportunities
               3.6.3.1 Targeted Therapy and Personalized Medicine spurs Microarray Industry
               3.6.3.2 Microarrays expected to become a powerful tool on glycomics study
3.7 Porter’s Five Force Analysis for the Global Array Instruments Market
      3.7.1 Bargaining Power of Suppliers
      3.7.2 Bargaining Power of Buyers
      3.7.3 Threat of Substitutes
      3.7.4 Threat from New Entrants
      3.7.5 Competitive Rivalry
3.8 Market Attractiveness Analysis: Global Array Instruments Market, by Geography
3.9 Competitive Landscape
      3.9.1 Market Share Analysis: Global Array Instruments Market, 2013 (value %)

Chapter 4 Global Array Instruments Market, by Technology
4.1 Introduction
      4.1.1 Global Array Instruments Market Revenue, by Technology, 2012 - 2020 (USD Million)
4.2 Comparative Analysis: Global Array Instruments Market, by Technology, 2013 & 2020 (Value %)
4.3 DNA Microarrays
      4.3.1 Global DNA Microarrays Market Revenue, 2012 – 2020 (USD Million)
4.4 Protein Microarrays
      4.4.1 Global Protein Microarrays Market Revenue, 2012 – 2020 (USD Million)
4.5 Tissue Microarrays
      4.5.1 Global Tissue Microarrays Market Revenue, 2012 – 2020 (USD Million)
4.6 Cellular Microarrays
      4.6.1 Global Cellular Microarrays Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Global Array Instruments Market, by End-Users
5.1 Introduction
      5.1.1 Global Array Instruments Market Revenue, by End-users, 2012 - 2020 (USD Million)
5.2 Comparative Analysis: Global Array Instruments Market, by End-users, 2013 & 2020 (Value %)
5.3 Research and Development Laboratories
      5.3.1 Global Research and Development Laboratories Market Revenue, 2012 – 2020 (USD Million)
5.4 Clinical Diagnostic Labs
      5.4.1 Global Clinical Diagnostic Labs Market Revenue, 2012 – 2020 (USD Million)
5.5 Agriculture Research Centers
      5.5.1 Global Agriculture Research Centers Market Revenue, 2012 – 2020 (USD Million)
5.6 Veterinary Laboratories
      5.6.1 Global Veterinary Laboratories Market Revenue, 2012 – 2020 (USD Million)
5.7 Forensic Centers
      5.7.1 Global Forensic Centers Market Revenue, 2012 – 2020 (USD Million)

Chapter 6 Global Array Instruments Market, by Geography
6.1 Introduction
      6.1.1 Global Array Instruments Market Revenue, by Geography, 2012 - 2020 (USD Million)
6.2 North America
      6.2.1 North America Array Instruments Market Revenue, 2012 – 2020 (USD Million)
6.3 Europe
      6.3.1 Europe Array Instruments Market Revenue, 2012 – 2020 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Array Instruments Market Revenue, 2012 – 2020 (USD Million)
6.5 Rest of the World
      6.5.1 Rest of the World Array Instruments Market Revenue, 2012 – 2020 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategy
      8.1.5 Recent Developments
8.2 Agilent Technologies, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 ArrayIt Corporation
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Bio-Rad Laboratories, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Illumina, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Development
8.6 Molecular Devices, LLC
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Sigma-Aldrich Corporation
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Thermo Fisher Scientific
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments

List of Figures

FIG. 1 Global Array Instrument Market, Market Segmentation
FIG. 2 Global Array Instruments, Market Revenue, by End-users, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Array Instruments Market, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Force Analysis: Global Array Instruments Market
FIG. 5 Market Attractiveness Analysis: Global Array Instruments Market, by Geography
FIG. 6 Market Share Analysis: Global Array Instruments Market, 2013 (Value %)
FIG. 7 Comparative Analysis: Global Array Instruments Market, by Technology, 2013 & 2020 (Value %)
FIG. 8 Global DNA Microarrays Market Revenue, 2012 – 2020 (USD Million)
FIG. 9 Global Protein Microarrays Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Tissue Microarrays Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Cellular Microarrays Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Comparative Analysis: Global Array Instruments Market, by End-users, 2013 & 2020 (Value %)
FIG. 13 Global Research and Development Laboratories Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Clinical Diagnostic Labs Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Agriculture Research Centers Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Veterinary Laboratories Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global Forensic Centers Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 North America Array Instruments Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Europe Array Instruments Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Asia-Pacific Array Instruments Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Rest of the World Array Instruments Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Affymetrix, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Agilent Technologies, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 ArrayIt Corporation.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Bio-Rad Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Illumina, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Sigma-Aldrich Corporation, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 28 Thermo Fisher Scientific, Annual Revenue: 2011 – 2013 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Array Instruments Market
TABLE 3 Global Array Instruments Market Revenue, by Technology, 2012 - 2020 (USD Million)
TABLE 4 Global Array Instruments Market Revenue, by End-users, 2012 - 2020 (USD Million)
TABLE 5 Global Array Instruments Market Revenue, by Geography, 2012 - 2020 (USD Million)
TABLE 6 North America Array Instruments Market Revenue, by Technology, 2013-2020 (USD Million)
TABLE 7 Europe Array Instruments Market Revenue, by Technology, 2013-2020 (USD Million)
TABLE 8 Asia-Pacific Array Instruments Market Revenue, by Technology, 2013-2020 (USD Million)
TABLE 9 RoW Array Instruments Market Revenue, by Technology, 2013-2020 (USD Million)

Enquiry Before Buying


Free Market Analysis


Microarray is a collection of microscopic spots of DNA, RNA, oligonucleotides, proteins, peptides, cells, tissues and other compounds which are attached to a solid substrate. Other microarray platforms include use of microscopic beads. With the help of array instruments, these microarrays are used to measure gene expression levels simultaneously in a single reaction and also genotype multiple regions of genome. The global array instruments market is driven by the large number of patients awaiting diagnosis of the exact type of cancer, metabolic diseases, and post natal diseases along with the research on the causes and treatment for such diseases. Disease diagnosis and detection has been the most critical and beneficial microarray application for the diagnosis and prognosis of different types of diseases, majorly cancer.

At present, a broad range of microarray technologies are available in the market for research purpose. DNA microarray is the most traditional and widely accepted technology in the microarray field. Thus, it accounts for the largest share, in the total market, owing to improved accuracy and precision and wide acceptance by the end users. The advent of DNA microarray has accelerated the process of gene expression, disease diagnosis, drug discovery and SNP analysis. Protein microarray which is the second largest and the fastest growing technology is very effective in identifying protein-protein interactions, substrates of protein kinases and activities of proteins. Due to high throughput, high resolution and sensitivity, protein microarray is extensively used in proteomics for protein expression profiling. Gene expression is the largest application market followed by the drug discovery and diagnosis market. High cost associated with the instruments and need for expertise leads to decreased adoption of microarray technology, particularly in developing countries. Moreover, increase in awareness for disease diagnosis and introduction of cheaper instruments and reagents will together aid in maintaining the growing of microarray technologies. 

Cellular microarray and tissue microarray technologies are currently in nascent stage and have their own limitations. The major factors that limit the use of tissue microarray are tissue heterogeneity and high cost. Expensive nature of array instruments limits the use in general practice in several countries. Hence, researchers are working on constructing cost effective tissue microarrays. Certain drawbacks with the use of cellular microarray are related to sensitivity. Moreover, there is further need for development of automated image analysis and data acquisition.

Geographically, North America dominates the global microarray instruments market. Large proportion of technological advancement first is introduced in the U.S. since majority of the prime market players are domiciled in North America. Europe accounts for second position in the total market. Rising incidences of cancers and autoimmune diseases drive the demand for diagnosis and treatment of such diseases in the region. Simplification of analysis process, increased market consolidation, and cost containment of instruments and reagents will result in rapid adoption of research in microarrays field in the emerging markets. Developing countries in Asia-Pacific, the Middle East, Latin America and Africa would contribute to the growth of the global array instruments market. Advancement in technology leading to better specificity and sensitivity coupled with low cost and robustness would increase the demand for research using microarrays, which would boost the market growth. 

The leading players in the market for microarray instruments are Affymetrix, Inc., Illumina, Inc., Agilent Technologies, Molecular Devices, ArrayIt Corporation, ThermoFischer Scientific and others which include Bio-Rad Laboratories, ArrayJet, and Sigma Aldrich. Greater benefits are expected to be achieved by various companies with huge investments in automation of systems with improved analysis in the near future. 

global-array-instruments-market

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research